Akron
Beacon Journal...
To
test, or not to test?
Editorial
October 14, 2011
As
health-care consumers, most of us
heed the counsel of medical professionals, who long have advised
regular
screenings to catch prostate or breast cancers in the early stages,
when
treatment is effective and the odds of recovery are better. What, then,
when a
federal task force, based on an independent review of large clinical
trials,
advises against routine testing for prostate cancer?
Among
other conclusions, the review
found no benefit to the blood test for prostate-specific antigen, PSA.
For the
majority of men who are diagnosed, the disease grows so slowly that
they are
more likely to die of other causes. In many instances, treatment is
unnecessary
and may expose patients to greater risks than the disease, such as
complications from infections. In about 20 percent to 30 percent of
cases,
surgical or radiation treatment leads to incontinence, impotence or
both.
As
can be expected, the recommendation
to reverse a practice that is heavily promoted — and has become an
annual
ritual for many men — is generating some confusion and controversy.
There is no
shortage of patients convinced that they owe their survival to
screening and
early detection. Besides, the recommendation leaves men in the
difficult
position of concluding it is better not to know if they have prostate
cancer or
that they are better off ignoring it if they do get a diagnosis.
The
recommendation also touches on the
question of vested interests and the effectiveness of medical
practices, not to
mention the costs of unnecessary screenings and treatments. Many
urologists
have criticized the basis for the PSA recommendation, pointing out that
deaths
from prostate cancer have dropped significantly in the United States
with
increased PSA screenings.
In
the end, the recommendation points
to a more nuanced approach: For men at high risk, say, black men and
men with a
family history of the disease, the option is to continue with regular
screenings.
Read
this and other articles at the
Akron Beacon Journal
|